(Q34380992)

1 August 2017

1 reference

title

Antidiuretic hormone. Normal and disordered function (English)

1 reference

1 August 2017

Robertson GL

1

1 reference

1 August 2017

1 September 2001

1 reference

Endocrinology and Metabolism Clinics of North America

1 August 2017

1 reference

1 August 2017

30

1 reference

1 August 2017

3

1 reference

1 August 2017

671-94, vii

1 reference

Treatment of symptomatic hyponatremia and its relation to brain damage. A prospective study

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970207-3

7 January 2021

Neurodegeneration and diabetes: UK nationwide study of Wolfram (DIDMOAD) syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970207-3

7 January 2021

Dilution and concentration of the urine and the action of antidiuretic hormone.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970207-3

7 January 2021

Vasopressin receptors in health and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970207-3

7 January 2021

Cellular actions of vasopressin in the mammalian kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970207-3

7 January 2021

Diabetes insipidus in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970207-3

7 January 2021

Modern imaging of the pituitary

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970207-3

7 January 2021

Oropharyngeal regulation of water balance in polydipsic schizophrenics.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970207-3

7 January 2021

Genetic basis of familial neurohypophyseal diabetes insipidus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970207-3

7 January 2021

A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970207-3

7 January 2021

Vasopressin and oxytocin precursors as model preprohormones

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970207-3

7 January 2021

Aggravation of subclinical diabetes insipidus during pregnancy.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970207-3

7 January 2021

Disorders of water balance--hyponatraemia and hypernatraemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970207-3

7 January 2021

Syndrome of inappropriate antidiuresis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970207-3

7 January 2021

Osmoregulation, the secretion of arginine vasopressin and its metabolism during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970207-3

7 January 2021

Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970207-3

7 January 2021

Human platelet arginine vasopressin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970207-3

7 January 2021

Hyponatremia and inappropriate secretion of vasopressin (antidiuretic hormone) in patients with hypopituitarism

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970207-3

7 January 2021

Potent aquaretic agent. A novel nonpeptide selective vasopressin 2 antagonist (OPC-31260) in men.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970207-3

7 January 2021

Chromosomal assignment of human sequences encoding arginine vasopressin-neurophysin II and growth hormone releasing factor

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970207-3

7 January 2021

Abnormalities of thirst regulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970207-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970207-3

1 reference

7 January 2021

Acute aquaresis by the nonpeptide arginine vasopressin (AVP) antagonist OPC-31260 improves hyponatremia in patients with syndrome of inappropriate secretion of antidiuretic hormone (SIADH)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970207-3

7 January 2021

The treatment of hyponatremia: first, do no harm

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970207-3

7 January 2021

Correction of Antidiuresis by Demeclocycline

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970207-3

7 January 2021

Autosomal recessive familial neurohypophyseal diabetes insipidus with continued secretion of mutant weakly active vasopressin.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970207-3

7 January 2021

A Comparison of Plasma Vasopressin Measurements with a Standard Indirect Test in the Differential Diagnosis of Polyuria

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8529%2805%2970207-3

7 January 2021

10.1016/S0889-8529(05)70207-3

Identifiers

DOI

1 reference

1 August 2017

1 reference

PubMed ID

11571936